A new technology notification form for the Italian national HTA programme

29

May 2017

A new online form for the notification of health technologies has been made available by Agenas (the Agency for Regional Health Services) at the following link: http://htadm.agenas.it. The form, available in Italian and English, can be filled with information on the technology and its intended use by registered users (registration is open).

Notification can be made by any stakeholder in the Italian system, including manufacturer.

Submissions can be made at any time during the year and those received within 30th June and 31st December will be collected within a prioritisation list from which, during the following semester, the technologies to assess will be selected by a prioritisation process.

Prioritisation will be performed by the Cabina di Regia per l’HTA, a national steering committee for HTA, created in 2015-2016 by the Ministry of Health including representatives of the Ministry of Health, four Regions, Agenas, and the Italian medicine agency (AIFA).

Such steering committee is appointed to coordinate the national HTA programme by defining lines of action related to the assessment of medical technologies at national level involving also relevant stakeholders such as representatives of patients, citizens and industry.

The steering committee commissions the assessment to Agenas or to the HTA units within the national HTA network.

Health technology assessments do not have direct impact on reimbursement of medical technologies in Italy, however they indirectly impact adoption of technologies at regional and local level.

Subscribe to our biweekly newsletter not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more